Form 4 for OMDA Omada Health, Inc.
Accepted 2026-07-06 17:31:01 ET · period of report 2026-07-01 · accession 0001610717-26-000322 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-06 17:31 | 2026-07-01 | OMDA | Duffy Sean P. | CEO, Dir | M - OptEx | $7.05 | +25.9K | 424.8K | +6% | +$182.5K |
| DMT | 2026-07-06 17:31 | 2026-07-01 | OMDA | Duffy Sean P. | CEO, Dir | S - Sale+OE | $22.68 | -25.9K | 411.9K | -6% | -$587.2K |
| DMT | 2026-07-06 17:31 | 2026-07-01 | OMDA | Duffy Sean P. | CEO, Dir | M - OptEx | $0.00 | -25.9K | 116.1K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-01 | M | A | 12,944 | $5.82 | 424,805 | D | — | — | |
| 2 | Common | Common Stock | 2026-07-01 | S | D | 12,944 | $22.70 | 411,861 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F2) This transaction was executed in multiple trades at prices ranging from $22.23 to $23.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-07-01 | M | A | 12,942 | $8.28 | 424,803 | D | — | — | |
| 4 | Common | Common Stock | 2026-07-01 | S | D | 12,942 | $22.67 | 411,861 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F3) This transaction was executed in multiple trades at prices ranging from $22.095 to $22.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-07-01 | M | D | 12,944 | $0.00 | 155,427 | D | $5.82 · — to 2029-08-21 | 12,944 Common Stock | (F5) 100% of the shares subject to the option are fully vested and exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-07-01 | M | D | 12,942 | $0.00 | 116,077 | D | $8.28 · — to 2031-05-05 | 12,942 Common Stock | (F5) 100% of the shares subject to the option are fully vested and exercisable. |